Our findings suggest that GIGYF2 may play an important role in the development of diabetes-associated cognitive impairment through modulating the phosphorylation of IGF1R and its downstream ERK1/2 signaling pathway, but not Akt signaling pathway. This evidence concerns the gene MAPK3 and Cognitive impairment.